Nature Made launches its first marquee billboard ad in Times Square
The new creative will debut during New Year’s Rockin’ Eve, Live from Times Square on CNN, NYE Prime Nashville’s Big Bash, and College Football Playoff programming on New Year’s Day.
The new creative will debut during New Year’s Rockin’ Eve, Live from Times Square on CNN, NYE Prime Nashville’s Big Bash, and College Football Playoff programming on New Year’s Day.
$17M Series B round led by Aquiline to fuel Scripta’s growth into health plan and Medicare Advantage markets.
Congress fumbled a chance to rein in big insurance and PBMs and save taxpayers billions, says NCPA.
CRN calls for a science-driven FDA strategy, highlighting extensive research backing dietary supplements.
PQA Health Equity Technical Expert Panel recommendations inform measure testing, use in quality programs, and risk adjustment models.
The continuing resolution to fund the government failed a House vote, 235 to 174.
Aetna expands app functionality to better connect with Spanish-speaking members
DOJ’s intervention follows the complaint originally filed by Baron & Budd in 2019.
Barnes brings extensive health care management experience to the company.
But Congress must ignore big insurance and the PBM lobby’s last-ditch effort to scuttle reforms and pass the continuing resolution.
NACDS is hailing PBM reforms contained in the 118th Congress’ culminating legislative package, and is urging the U.S. House of Representatives and U.S. Senate to advance this continuing resolution to President Biden’s desk for signature.
Erlotinib tablets are a kinase inhibitor indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC).
"We are honored to be recognized by Forbes as one of the Best Employers for Tech Workers and for our unparalleled customer service specifically in pharmacy."
Quincy Bioscience, the dietary supplement maker, must stop making specific advertising claims deemed deceptive.
With the growing demand for PBM reform, Trump has stated that action must be taken.
Pharmacy leaders demand Congress address PBM practices.